IAA23 Antibody

Basic Research Questions

• What is IAA23 Antibody and what cellular targets does it recognize?

  IAA23 Antibody is a research reagent that specifically recognizes the IAA23 protein (Auxin-responsive protein IAA23) in Oryza sativa subsp. japonica (Rice), corresponding to UniProt accession Q69VE0 . This antibody is part of the broader family of reagents used to study auxin-regulated gene expression and plant development. IAA23 belongs to the Aux/IAA family of proteins that function as transcriptional regulators in the auxin signaling pathway, playing crucial roles in plant growth and developmental processes.

• How should IAA23 Antibody be handled and stored for optimal performance?

  For optimal performance in experimental applications, IAA23 Antibody should be stored at -20°C for long-term preservation. When handling the antibody, minimize freeze-thaw cycles by aliquoting upon first thaw. Working dilutions should be prepared fresh before use, and the antibody should be handled using low-protein binding tubes. For short-term storage (1-2 weeks), 4°C is acceptable. Always centrifuge antibody vials briefly before opening to ensure collection of all material at the bottom of the tube.

• What detection methods are compatible with IAA23 Antibody?

  IAA23 Antibody is compatible with multiple detection methodologies including:

  • Western blotting (recommended dilution 1:500-1:2000)

  • Immunohistochemistry (recommended dilution 1:100-1:500)

  • Immunofluorescence (recommended dilution 1:100-1:500)

  • ELISA (recommended dilution 1:1000-1:5000)

  Optimization of dilutions is necessary for each specific application and experimental system. When designing experiments, consider including appropriate positive and negative controls to validate antibody performance.

• How is IAA23 Antibody different from insulin autoantibodies (IAA) studied in diabetes research?

  Despite the similar abbreviation, IAA23 Antibody targeting plant Auxin-responsive protein IAA23 is entirely distinct from insulin autoantibodies (IAA) in diabetes research. The IAA in diabetes contexts refers to autoantibodies against insulin that are important markers of diabetes-associated autoimmunity . These autoantibodies are used to identify people at increased risk for developing type 1 diabetes or requiring insulin treatment . When reviewing literature, researchers should carefully distinguish between these different antibodies based on their biological context and target recognition.

Advanced Research Questions

• What methodologies are recommended for validating the specificity of IAA23 Antibody in cross-species applications?

  When applying IAA23 Antibody across different plant species, rigorous validation is essential. The recommended approach includes:

  1. Sequence homology analysis between target IAA23 proteins from different species

  2. Western blot analysis with recombinant proteins representing the target from each species

  3. Competitive binding assays using purified target proteins

  4. Knockout/knockdown validation experiments in the non-native species

  5. Epitope mapping to confirm conservation of binding sites

  Additionally, researchers should perform parallel experiments with alternative antibodies targeting different epitopes of the same protein to corroborate findings. For plant species with significant divergence from rice, preliminary epitope conservation analysis is strongly recommended before experimental application.

• How can IAA23 Antibody be effectively employed in studies examining auxin-mediated stress responses in plants?

  For investigating auxin-mediated stress responses, IAA23 Antibody can be integrated into multiple experimental approaches:

  1. Chromatin immunoprecipitation (ChIP) assays to identify IAA23 binding to promoter regions during stress conditions

  2. Co-immunoprecipitation (Co-IP) to characterize IAA23 interaction partners under different stress stimuli

  3. Immunolocalization to track IAA23 subcellular redistribution during stress response

  4. Quantitative western blotting to monitor IAA23 protein levels in response to abiotic stressors

  Experimental designs should include appropriate time-course analyses to capture the dynamic nature of auxin signaling responses. When studying drought or temperature stress responses specifically, sample collection timing is critical as IAA23 protein levels may fluctuate rapidly during stress onset, acclimation, and recovery phases.

• What are the considerations for using IAA23 Antibody in phosphorylation status analysis of IAA proteins?

  When investigating phosphorylation states of IAA23 proteins, researchers should consider:

  1. Selection of extraction buffers containing appropriate phosphatase inhibitors

  2. Use of Phos-tag™ SDS-PAGE or similar technologies to separate phosphorylated forms

  3. Parallel analysis with phospho-specific antibodies when available

  4. Pre-treatment of samples with phosphatases as negative controls

  5. Mass spectrometry validation of phosphorylation sites

  It's important to note that standard IAA23 Antibody may recognize both phosphorylated and non-phosphorylated forms with varying affinity. For definitive phosphorylation analysis, combining immunoprecipitation with IAA23 Antibody followed by mass spectrometry analysis provides the most comprehensive characterization of phosphorylation sites and their occupancy.

• How does IAA23 Antibody performance compare in different tissue types and developmental stages?

  IAA23 Antibody performance varies across tissue types and developmental stages due to several factors:

  1. Variable IAA23 expression levels between tissues and developmental stages

  2. Tissue-specific post-translational modifications that may affect epitope accessibility

  3. Different extraction efficiencies from various tissue types

  4. Presence of tissue-specific interfering compounds

  To optimize performance:

  • Adjust extraction protocols for specific tissues (e.g., higher detergent concentrations for lignified tissues)

  • Optimize blocking conditions to minimize background in tissues with high endogenous peroxidase activity

  • Use tissue-specific positive controls at relevant developmental stages

  • Consider native protein conformation in different developmental contexts

  For reproductive tissues and meristematic regions where auxin signaling is particularly dynamic, more stringent validation may be required.

• What approaches can be used to resolve contradictory results when using IAA23 Antibody in conjunction with transcriptomic data?

  When faced with discrepancies between IAA23 Antibody-based protein detection and transcriptomic data, consider these methodological approaches:

  1. Temporal analysis to account for delays between transcription and translation

  2. Protein stability assessment using cycloheximide chase assays

  3. Analysis of post-transcriptional regulation mechanisms (miRNA targeting, etc.)

  4. Polysome profiling to evaluate translational efficiency

  5. Alternative antibody validation using orthogonal methods

  It's important to recognize that auxin-responsive proteins often exhibit complex post-transcriptional regulation, including controlled protein degradation via the ubiquitin-proteasome system. Therefore, transcript levels may not directly correlate with protein abundance. In such cases, combining IAA23 Antibody detection with proteasome inhibitors (like MG132) in parallel experiments can help elucidate whether protein turnover accounts for observed discrepancies.

• How can IAA23 Antibody be incorporated into quantitative proteomics workflows?

  For quantitative proteomics applications, IAA23 Antibody can be integrated through:

  1. Immunoprecipitation coupled with mass spectrometry (IP-MS) to identify interaction partners

  2. Sequential Window Acquisition of all Theoretical fragment ion spectra (SWATH-MS) following enrichment

  3. Selected Reaction Monitoring (SRM) of IAA23-derived peptides after digestion

  4. Tandem Mass Tag (TMT) labeling for multiplexed quantitation across conditions

  When designing quantitative experiments, consider:

  • Including isotype control antibodies to assess non-specific binding

  • Spiking known quantities of recombinant IAA23 protein for absolute quantification

  • Optimizing digestion protocols to maximize recovery of IAA23 signature peptides

  • Collaborating with proteomics specialists to develop IAA23-specific SRM assays

  The combination of immunoprecipitation with IAA23 Antibody followed by mass spectrometry provides powerful insights into auxin signaling complexes beyond what can be achieved with antibody-based detection alone.

• What are the methodological considerations when using IAA23 Antibody in CRISPR-edited plant systems?

  When applying IAA23 Antibody in CRISPR-modified plant systems, researchers should consider:

  1. Epitope preservation analysis to ensure CRISPR edits haven't altered the antibody binding site

  2. Western blot validation comparing wild-type and edited lines

  3. Off-target effects of CRISPR editing that might affect IAA23 expression

  4. Appropriate controls including wild-type, knockout, and tagged-protein lines

  5. Potential compensatory regulation of other IAA family members

  For tagged fusion proteins, researchers should verify that the tag doesn't interfere with antibody binding. Additionally, when using IAA23 Antibody in conjunction with CRISPR-mediated gene regulation systems like CRISPRa/CRISPRi, calibration experiments are essential to correlate antibody signal with varying levels of target expression.

• How can researchers distinguish between IAA23 and other closely related IAA family members using antibody-based approaches?

  To distinguish IAA23 from other IAA family members, implement these methodological strategies:

  1. Bioinformatic analysis to identify unique epitopes in IAA23 versus related proteins

  2. Competitive binding assays with recombinant IAA proteins

  3. Multi-antibody approaches targeting different IAA proteins

  4. Pre-absorption controls with recombinant related proteins

  5. Validation in transgenic lines with modified expression of specific IAA family members

  When interpreting results, consider the high sequence similarity between IAA family members, particularly in conserved domains. For definitive discrimination, combining antibody-based detection with gene-specific approaches like RT-qPCR can provide complementary evidence. In systems where multiple IAA proteins are expressed, immunoprecipitation followed by mass spectrometry may offer higher specificity than immunodetection alone.